Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1394 Preclinical characterization of biodegradable injectable antigen presenting nanoparticles AIM INJ for in vivo treatment of solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.